The Centre National de la Recherche Scientifique, 2007 S4 checked by TLC for completeness. A precipitate should form. Once done, the reaction solution was diluted with ether, filtered through a pad of Celite and concentrated. The residue was then purified using Silica flash chromatography using the solvents indicated.
N,N-Diethyl-N'-(2-Iodo-4-benzoic acid) triazene (S) 2-methylbutyl ester (7)
A solution of 5.00g of 6 (14.4 mmol, 1.0 eq) and 2.83 g of DMAP (23.0 mmol, 1.6 eq) was prepared in 142 mL of DCM This solution was cooled to 0 o C and 4.41 g of EDC (23.0 mmol, 1.6 eq) was added. After 20 minutes, 1.27 g of (S) 2-methylbutanol was added in 50 mL DCM. The reaction was stirred overnight, during which time the ice was allowed to melt. The mixture was evaporated, and the residue partitioned between 50 mL of water and 2 250 mL portions of DCM. The organic layer was washed with brine, dried over MgSO 4 , and evaporated to give crude product. Purification by flash chromatography in 20->50% DCM/Hexanes gave a light yellow oil (4.27g, 71%). 
N,N-Diethyl-N'-(2-trimethylsilanylethynyl-4-benzoic acid) triazene (S) 2-methylbutyl ester (8)
The general Sonogashira coupling procedure described above was used to prepare this compound. 1.93 g of 7 (4.61 mmol, 1.0 eq), 162 mg of Pd(Pφ 3 ) 2 Cl 2 (0.23 mmol, 0.05 eq), and 9 mg CuI (0.05 mmol, 0.01 eq) were combined in a 100 mL schlenk flask with 31 mL TEA. TMS acetylene (0.974 mL/0.697 g, 6.92 mmol, 1.5 eq) was added to the solution. Reaction was stirred overnight at room temperature. After completion, the reaction solution was filtered through Celite with ether to wash, evaporated, and purified with flash chromatography in 0%->20% EtOAc/hexanes to give a light yellow oil (1.60 g, 90%) . 1 (S) 2-methylbutyl 3-trimethylsilanylethynyl 4-iodo benzoate (9) The general Triazene Activation Procedure described above was used to prepare this compound. 580 mg of 8 (1.29 mmol, 1.0 eq) and 33 mg of I 2 (0.13 mmol, 0.1 eq) were dissolved in 10 mL of CH 3 I, divided into 2 Biotage vials, and each portion was microwaved for 1 hour at 150 o C. Reaction was worked up as described above, and purified with flash chromatography in 0%->30% EtOAc/hexanes to give a light yellow oil (572 mg, 92%). The general TMS deprotection procedure, listed above, was used to prepare this compound. 290 mg of 8 (0.801 mmol, 1.0 eq) and 376 mg of KF.2H 2 O (4.0 mmol, 5.0 eq) were dissolved in 5 mL of DMF and stirred for 4 hours. The mixture was diluted with 50 mL CHCl 3 and washed with 25 mL of H 2 O and 25 mL of saturated CaCl 2 before evaporation to give a yellow oil which was taken directly on to 11 without further purification.
Triazene-C
5 -Es-TMS (11) This compound was prepared using the general Sonogashira coupling procedure described above. 0.801 mmol of 10 and 393 mg of 3 (0.801 mmol, 1.0 eq) were coupled in 20 mL of 1:1 TEA/THF using 28 mg (0.042 mmol, 0.05 eq) of Pd(Pφ 3 ) 2 Cl 2 and 1.5 mg (0.008 mmol, 0.01 eq) of CuI as described in the general procedure. The product was purified by flash chromatography in 0%->60% EtOAc/hex to give an orange oil (398 mg, 73%). 
I-C 5 -Es-TMS (12)
The general Triazene Activation Procedure described above was used to prepare this compound. 871 mg of 11 (1.28 mmol, 1.0 eq) and 65 mg of I 2 (0.257 mmol, 0.30 eq) were dissolved in 9 mL of CH 3 I, divided into 2 Biotage vials, and each portion was microwaved for 1 hour at 150 o C. Reaction was worked up as described above, and purified with flash chromatography in 0%->20% acetone/CHCl 3 to give an orange oil (506 mg, 56%). Triazene-Es-C 5 -TMS (13) This compound was prepared using the general Sonogashira coupling procedure described above. 1.97 mmol of 4 and 816 mg of 9 (1.97 mmol, 1.0 eq) were coupled in 40 mL of 1:1 TEA/THF using 69 mg (0.098 mmol, 0.05 eq) of Pd(Pφ 3 ) 2 Cl 2 and 3.8 mg (0.019 mmol, 0.01 eq) of CuI as described in the general procedure. The product was purified by flash chromatography in 0%->60% EtOAc/hex to give an orange oil (398 mg, 73% 
I-Es-C 5 -TMS (14)
The general Triazene Activation Procedure described above was used to prepare this compound. 978 mg of 13 (1.44 mmol, 1.0 eq) and 73 mg of I 2 (0.288 mmol, 0.20 eq) were dissolved in 10 mL of CH 3 I, divided into 2 Biotage vials, and each portion was microwaved for 1 hour at 150 o C. Reaction was worked up as described above, and purified with flash chromatography in 0%->20% acetone/CHCl 3 to give an orange oil (506 mg, 56%). Triazene-Es-C 5 -Es-TMS (15) This compound was prepared by the general Sonogashira procedure described above. 111 mg of 4 (284 μmol, 1.0 eq), 200 mg of 12 (284 μmol, 1.0 eq), 10.0 mg of Pd(Pφ 3 ) 2 Cl 2 (14 μmol, 0.05 eq), and 0.6 mg CuI (3 μmol, 0.01 eq) were coupled in a Schlenk flask in 15 mL TEA and 30 mL THF. The reaction was heated at 55°C overnight, worked up as described in the general procedure, and purified by flash chromatography in 0->20% acetone/CHCl 3 to obtain an orange solid (350 mg, 87%). 
Triazene-Es-C5-Es-≡-H (16)
The general TMS deprotection procedure, listed above, was used to prepare this compound. 257 mg of 8 (265 μmol, 1.0 eq) and 125 mg of KF.2H 2 O (1330 μmol, 5.0 eq) were dissolved in 5 mL of DMF and stirred for 4 hours. The mixture was diluted with 25 mL CHCl 3 and washed with 15 mL of H 2 O and 15 mL of saturated CaCl 2 before evaporation to give an orange oil which was taken directly on to 17 without further purification.
Triazene-Es-C 5 -Es-Es-C 5 -TMS (17)
This compound was prepared by the general Sonogashira procedure described above. 265 μmol of 16 (1.0 eq), The Centre National de la Recherche Scientifique, 2007 S7 187 mg of 14 (265 μmol, 1.0 eq), 9.3 mg of Pd(Pφ 3 ) 2 Cl 2 (14 μmol, 0.05 eq), and 0.5 mg CuI (2.7 μmol, 0.01 eq) were coupled in a Schlenk flask in 15 mL TEA and 30 mL THF. The reaction was heated at 55°C overnight, worked up as described in the general procedure, and purified by flash chromatography in 0->30% acetone/CHCl 3 to obtain an orange solid (158 mg, 38%). 
Triazene-Es-C 5 -Es-Es-C 5 -≡-H (18)
The general TMS deprotection procedure, listed above, was used to prepare this compound. 158 mg of 17 (107 μmol, 1.0 eq) and 47 mg of KF.2H 2 O (500 μmol, 4.7 eq) were dissolved in 5 mL of DMF and stirred for 4 hours. The mixture was diluted with 25 mL CHCl 3 and washed with 15 mL of H 2 O and 15 mL of saturated CaCl 2 before evaporation to give an orange oil which was taken directly on to 1 or to 19 without further purification.
Triazene-Es-C
5 -Es-Es-C 5 -Es-TMS (1) This compound was prepared by the general Sonogashira procedure described above. 70 μmol of 18 (1.0 eq), 77 mg of 3 (77 μmol, 1.1 eq), 2.4 mg of Pd(Pφ 3 ) 2 Cl 2 (4 μmol, 0.05 eq), and 0.1 mg CuI (0.7 μmol, 0.01 eq) were coupled in a Schlenk flask in 15 mL TEA and 30 mL THF. The reaction was heated at 55°C overnight, worked up as described in the general procedure, and purified by flash chromatography in 0->40% acetone/CHCl 3 to obtain an orange solid (74 mg, 59%). 135.021, 133.202, 133.084, 133.015, 132.723, 132.390, 132.144, 132.050, 131.702, 130.573, 130.538, 129.848, 129.825, 129.629, 129.485, 129.444, 129.387, 129.327, 129.298, 129.247, 129.106, 129.006, 128.966, 128.886, 125.736, 125.581, 125.397, 125.344, 125.246, 124.923, 117,451, 116,356, 102,303, 100,006 (C≡), 99,953 (C≡) The Centre National de la Recherche Scientifique, 2007 S8 70.552, 70.511, 69.927, 69.830, 69.156, 69.083, 69.052, 64.343, 64.291, 63.900, 58.984, 49.322, 42.095, 34.218, 34.171, 26.084, 16.491, 16.414, 14.315, 11.277, 11.205, 11.184, 10.886, 0.023 (Si(CH 3 Triazene-Es-C 5 -Es-Es-C 5 -Es-Es-TMS (19) This compound was prepared by the general Sonogashira procedure described above. 107 μmol of 18 (1.0 eq), 83 mg of 5 (107 μmol, 1.0 eq), 3.8 mg of Pd(Pφ 3 ) 2 Cl 2 (5.4 μmol, 0.05 eq), and 0.2 mg CuI (1.1 μmol, 0.01 eq) were coupled in a Schlenk flask in 15 mL TEA and 30 mL THF. The reaction was heated at 55°C overnight, worked up as described in the general procedure, and purified by flash chromatography in 0->40% acetone/CHCl 3 to obtain an orange solid (94 mg, 43%). The general TMS deprotection procedure, listed above, was used to prepare this compound. 94 mg of 19 (45.8 μmol, 1.0 eq) and 21 mg of KF.2H 2 O (229 μmol, 5.0 eq) were dissolved in 2 mL of DMF and stirred for 4 hours. The mixture was diluted with 10 mL CHCl 3 and washed with 5 mL of H 2 O and 5 mL of saturated CaCl 2 before evaporation to give an orange oil which was taken directly on to 2 without further purification.
5 -Es-Es-C 5 -Es-Es-C 5 -Es-TMS (2) This compound was prepared by the general Sonogashira procedure described above. 45.8 μmol of 20 (1.0 eq), 33 mg of 12 (45.8 μmol, 1.0 eq), 1.6 mg of Pd(Pφ 3 ) 2 Cl 2 (2.3 μmol, 0.05 eq), and 0.1 mg CuI (0.5 μmol, 0.01 eq) were coupled in a Schlenk flask in 15 mL TEA and 30 mL THF. The reaction was heated at 55°C overnight, worked up as 
